Trevena Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
76.08 M |
Public Float |
62.05 M |
Trevena Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.35 |
Market Cap |
$95.12 M |
Shares Outstanding |
92.35 M |
Public Float |
76.87 M |
Address |
955 Chesterbrook Boulevard Chesterbrook Pennsylvania 19087 United States |
Employees | - |
Website | http://www.trevenainc.com |
Updated | 07/08/2019 |
Trevena, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of healthcare services and development of therapies. The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. |